WP
Woodline Partners’s Vaxcyte PCVX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.5M | Sell |
200,078
-911,699
| -82% | -$29.6M | 0.03% | 513 |
|
|
2025
Q1 | $42M | Sell |
1,111,777
-9,145
| -0.8% | -$345K | 0.27% | 112 |
|
|
2024
Q4 | $91.8M | Buy |
1,120,922
+16,977
| +2% | +$1.39M | 0.62% | 20 |
|
|
2024
Q3 | $126M | Buy |
1,103,945
+397,042
| +56% | +$45.4M | 1.06% | 5 |
|
|
2024
Q2 | $53.4M | Buy |
706,903
+313,199
| +80% | +$23.6M | 0.51% | 51 |
|
|
2024
Q1 | $26.9M | Buy |
393,704
+353
| +0.1% | +$24.1K | 0.25% | 126 |
|
|
2023
Q4 | $24.7M | Buy |
393,351
+12,738
| +3% | +$800K | 0.27% | 116 |
|
|
2023
Q3 | $19.4M | Sell |
380,613
-9,843
| -3% | -$502K | 0.23% | 136 |
|
|
2023
Q2 | $19.5M | Buy |
390,456
+140,456
| +56% | +$7.01M | 0.23% | 130 |
|
|
2023
Q1 | $9.37M | Hold |
250,000
| – | – | 0.13% | 206 |
|
|
2022
Q4 | $12M | Buy |
250,000
+53,571
| +27% | +$2.57M | 0.16% | 175 |
|
|
2022
Q3 | $4.71M | Sell |
196,429
-269,895
| -58% | -$6.48M | 0.07% | 304 |
|
|
2022
Q2 | $10.1M | Buy |
+466,324
| New | +$10.1M | 0.16% | 172 |
|
|
2022
Q1 | – | Sell |
-97,396
| Closed | -$2.32M | – | 800 |
|
|
2021
Q4 | $2.32M | Buy |
+97,396
| New | +$2.32M | 0.03% | 400 |
|
|
2020
Q3 | – | Sell |
-23,026
| Closed | -$728K | – | 210 |
|
|
2020
Q2 | $728K | Buy |
+23,026
| New | +$728K | 0.03% | 142 |
|